President Trump, who has repeatedly assailed pharmaceutical companies for the high cost of prescription medications in the United States, nominated on Monday a former executive of one of the nation’s largest drug companies to be secretary of health and human services, which has responsibility for regulating the pharmaceutical industry.
SOURCE – READ THE FULL ARTICLE AT: https://www.nytimes.com/2017/11/13/us/politics/alex-azar-health-human-services-trump.html?hl=en&ned=us